Australia markets closed

Bausch + Lomb Corporation (BLCO)

NYSE - Nasdaq Real-time price. Currency in USD
Add to watchlist
15.82-0.11 (-0.69%)
At close: 04:00PM EDT
15.45 -0.37 (-2.34%)
After hours: 06:23PM EDT
Full screen
Trade prices are not sourced from all markets
Previous close15.93
Open15.86
Bid0.00 x 1000
Ask0.00 x 900
Day's range15.61 - 15.89
52-week range13.16 - 17.85
Volume118,264
Avg. volume581,995
Market cap5.567B
Beta (5Y monthly)0.46
PE ratio (TTM)N/A
EPS (TTM)-1.29
Earnings date31 July 2024
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target est27.22
  • Simply Wall St.

    Bausch + Lomb Insider Ups Holding During Year

    From what we can see, insiders were net buyers in Bausch + Lomb Corporation's ( NYSE:BLCO ) during the past 12 months...

  • GuruFocus.com

    Insider Buying: CEO Brent Saunders Acquires Shares of Bausch & Lomb Corp

    The transaction was filed with the SEC and indicates a strong signal of confidence from the insider. Following this acquisition, the insider now owns 627,419 shares of Bausch & Lomb Corp. Bausch & Lomb Corp is primarily engaged in the development, manufacture, and marketing of a range of pharmaceutical, medical device, and over-the-counter products, particularly in eye health.

  • Business Wire

    Bausch + Lomb Announces Second-Quarter 2024 Results

    VAUGHAN, Ontario, July 31, 2024--Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, today announced its second-quarter 2024 financial results.